DoD Kidney Cancer, Academy of Kidney Cancer Investigators - Early-Career Scholar Award
ID: 355337Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355337
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the DoD Kidney Cancer, Academy of Kidney Cancer Investigators - Early-Career Scholar Award, aimed at enhancing kidney cancer research by supporting early-career scholars. This grant opportunity encourages applicants to conduct innovative research relevant to service members, veterans, and the general public, with a focus on understanding kidney cancer biology, developing new therapeutics, and improving patient care. The program has an estimated total funding of $2.32 million, with two awards anticipated, and requires a pre-application letter of intent by September 24, 2024, followed by a full application due on October 15, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524KCRPAKCIECS_GG.pdf
    The Department of Defense's FY24 Kidney Cancer Academy of Kidney Cancer Investigators – Early-Career Scholar Award aims to enhance kidney cancer research by soliciting applications from early-career scholars. This funding opportunity, with a budget of $50 million allocated for fiscal year 2024, supports innovative research that is relevant to service members, veterans, and the general public. Applicants must align their research with the program's overarching strategic goals, which emphasize understanding kidney cancer biology, developing new therapeutics, and improving patient care. Key eligibility criteria for applicants include being within five years of their last postdoctoral research or clinical fellowship, and having a designated mentor with a strong background in kidney cancer research. The application process is two-fold: a pre-application letter of intent is due by September 24, 2024, followed by a full application due on October 15, 2024. The award is intended to provide early-career researchers with the resources, mentorship, and networking opportunities necessary to establish independent careers in kidney cancer research, focusing on collaborative efforts across institutions. The document outlines comprehensive guidelines for application submission, review criteria, and funding limitations to facilitate impactful research endeavors.
    Similar Opportunities
    Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Institutional Network Award (U2C) to enhance training in kidney, urologic, and hematologic research. This funding opportunity aims to foster a collaborative environment by inviting institutions to submit a unified application that supports a cohort of trainees and early-career investigators, with a strong emphasis on partnerships among institutions within metropolitan areas. The initiative is crucial for reshaping research training and promoting scientific collaboration, ensuring that the next generation of researchers is equipped to address complex biomedical challenges. Applications will be accepted starting October 16, 2023, with a submission deadline of September 27, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for Academic Career Excellence (ACE) Award (K32 � Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing the upcoming Academic Career Excellence (ACE) Award (K32), aimed at supporting late-stage graduate students and early-stage postdoctoral scholars in cancer research. This grant opportunity is designed to enhance the scientific research and career development experience of candidates transitioning to postdoctoral positions, requiring applicants to have a well-defined research and training plan with an identified mentor. The ACE Award is critical for fostering the next generation of cancer researchers, with applications expected to open on June 12, 2025, and an estimated award date of March 2, 2026. Interested applicants should prepare their proposals in advance, as there are no cost-sharing requirements, and the funding will be available under CFDA number 93.398.
    Notice of Intent to Publish Funding Opportunity Announcement for NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32 - Independent Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is planning to publish a Notice of Funding Opportunity for the NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32), which will support early postdoctoral fellows in cancer research. This grant program aims to enhance the pool of qualified individuals from diverse backgrounds for careers in health-related research, particularly in cancer, by providing research training opportunities that do not require preliminary data. The program is significant for addressing cancer health disparities and enriching the scientific research experience for trainees transitioning from pre-doctoral to post-doctoral training. Interested applicants must identify a postdoctoral research mentor and submit their applications through their respective institutions, with the application deadline set for June 12, 2025, and an estimated award date of March 2, 2026.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32 � Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing the upcoming availability of the NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32), which will support early postdoctoral fellows in cancer research. This grant program aims to enhance the pool of qualified individuals from diverse backgrounds for careers in health-related research, particularly in cancer research, by providing research training opportunities without requiring preliminary data. The application process will open on June 12, 2025, with an estimated award date of March 1, 2026, and interested applicants must identify a postdoctoral mentor and submit their applications through their respective institutions. For more information, applicants can refer to the NIH website or contact the agency directly.
    NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22), aimed at supporting senior postdoctoral fellows in their transition to independent research roles. This grant specifically targets candidates from diverse backgrounds, with the objective of fostering an inclusive research workforce and enhancing cancer research capabilities. The K22 award provides three years of salary and research funding, encouraging the development of independent research projects, particularly those leading to clinical trials. Interested applicants must adhere to NIH guidelines and submit their applications by January 7, 2028, with further details available at NIH Grants. For inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08), aimed at training individuals with clinical doctoral degrees for impactful careers in health-related research, particularly in cancer studies. This program is designed to support individuals from underrepresented backgrounds in health-related sciences, providing them with a mentored research career development experience over a period of 3 to 5 years, focusing on biomedical, behavioral, and clinical research, including clinical trials. Successful applicants are expected to commit at least 75% of their time to the project and will receive funding for salary and research-related expenses, with applications due at specific intervals starting January 12, 2025. For further information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-319.html.
    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Development Command (USAMRDC), has announced the FY23-FY27 Broad Agency Announcement (BAA) for Extramural Medical Research, which is open for submissions from October 1, 2022, to September 30, 2027. This opportunity invites innovative research proposals that address critical military medical challenges, particularly in the areas of Military Infectious Diseases, Combat Casualty Care, and Military Operational Medicine, with a focus on enhancing medical practices for both military personnel and civilians. The BAA emphasizes the importance of collaboration with Department of Defense and Department of Veterans Affairs resources and requires adherence to strict submission guidelines via Grants.gov and the electronic Biomedical Research Application Portal (eBRAP). Interested applicants can submit pre-proposals at any time during the five-year period, with full proposals invited based on initial submissions, and should direct inquiries to the CDMRP Help Desk at help@eBRAP.org.
    NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08), aimed at fostering diversity within the cancer research workforce. This grant supports clinical scientists with doctoral degrees who are underrepresented in health-related research, providing salary support for a 3-5 year period to gain intensive research training in various cancer research fields, particularly focusing on health disparities. The program is designed to enhance the research capabilities of awardees, preparing them for independent research careers in basic biomedical, behavioral, or translational cancer research. Interested applicants should note that the application period opens on January 12, 2025, with a submission deadline of February 12, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-320.html.
    Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced a funding opportunity titled "Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)." This initiative aims to support exploratory research projects that focus on the early-stage development of innovative technologies for molecular and cellular analysis in cancer research, with an emphasis on enhancing characterization of cancer biology and addressing health disparities. Eligible applicants include a wide range of organizations, such as higher education institutions, non-profits, and tribal governments, with funding available up to $150,000 annually for a project period not exceeding three years. The total estimated funding for this program is approximately $4.2 million, with about 17 awards expected to be made. Interested applicants can find more information and submit inquiries via email to grantsinfo@nih.gov, with applications due by October 3, 2025.
    The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12), aimed at supporting newly trained clinicians committed to independent research careers in community oncology and cancer prevention. This grant opportunity encourages the development of community-based clinical trials and ancillary studies, with a strong emphasis on addressing health disparities and improving access to cancer clinical trials for underserved populations. Eligible applicants include a diverse range of organizations, particularly those serving underrepresented groups, with funding available for up to five years to support program planning and mentorship. Interested parties can find more information and application details at the NIH grants website, with the application deadline set for February 18, 2027.